Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters
Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters
Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters
Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters

WHO recommends molnupiravir for Covid patients who may need hospital treatment


Soraya Ebrahimi
  • English
  • Arabic

The antiviral drug molnupiravir has been recommended by the World Health Organisation for patients with non-severe Covid-19 who are at the highest risk of requiring hospital treatment.

Patients who are at highest risk of needing hospital treatment typically include those who are unvaccinated, older people and those with weak immune systems or chronic diseases.

However in its report in The BMJ, the WHO panel said that young and healthy patients, including children and pregnant and breastfeeding women, should not be given the drug due to potential harms.

Molnupiravir is an antiviral that works by stopping coronavirus from growing and spreading. Used as early as possible after infection, it can help prevent more severe symptoms from developing.

Thursday’s recommendation is based on new data from six randomised controlled trials involving 4,796 patients. This is the largest data set on this drug so far.

Moderate certainty evidence from these trials suggests that molnupiravir reduces the risk of hospital admission (43 fewer admissions per 1,000 patients at highest risk) and time to symptom resolution (average 3.4 fewer days), while low certainty evidence suggests a small effect on mortality (6 fewer deaths per 1,000 patients).

The panel made no recommendation for patients with severe or critical illness as there are no trial data on molnupiravir for this population.

And it acknowledged that cost and availability issues associated with molnupiravir may make access to the drug for low- and middle-income countries challenging and exacerbate health inequity.

The panel also recommended a treatment combining two antibodies (casirivimab and imdevimab) to be used in people who are confirmed not to have the Omicron variant, as new evidence demonstrates a lack of effectiveness against it.

The guidance adds to previous recommendations for the use of Baricitinib, interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical Covid-19; for the use of sotrovimab for patients with non-severe Covid-19; and against the use of convalescent plasma, ivermectin and hydroxychloroquine in patients with Covid-19, regardless of disease severity.

The recommendation for remdesivir is undergoing review due to new trial data. Recommendations for fluvoxamine and nirmatrelvir/ritonavir are currently in preparation.

HIJRA

Starring: Lamar Faden, Khairiah Nathmy, Nawaf Al-Dhufairy

Director: Shahad Ameen

Rating: 3/5

Volvo ES90 Specs

Engine: Electric single motor (96kW), twin motor (106kW) and twin motor performance (106kW)

Power: 333hp, 449hp, 680hp

Torque: 480Nm, 670Nm, 870Nm

On sale: Later in 2025 or early 2026, depending on region

Price: Exact regional pricing TBA

UAE currency: the story behind the money in your pockets
UAE currency: the story behind the money in your pockets
Grand Slam Los Angeles results

Men:
56kg – Jorge Nakamura
62kg – Joao Gabriel de Sousa
69kg – Gianni Grippo
77kg – Caio Soares
85kg – Manuel Ribamar
94kg – Gustavo Batista
110kg – Erberth Santos

Women:
49kg – Mayssa Bastos
55kg – Nathalie Ribeiro
62kg – Gabrielle McComb
70kg – Thamara Silva
90kg – Gabrieli Pessanha

Start-up hopes to end Japan's love affair with cash

Across most of Asia, people pay for taxi rides, restaurant meals and merchandise with smartphone-readable barcodes — except in Japan, where cash still rules. Now, as the country’s biggest web companies race to dominate the payments market, one Tokyo-based startup says it has a fighting chance to win with its QR app.

Origami had a head start when it introduced a QR-code payment service in late 2015 and has since signed up fast-food chain KFC, Tokyo’s largest cab company Nihon Kotsu and convenience store operator Lawson. The company raised $66 million in September to expand nationwide and plans to more than double its staff of about 100 employees, says founder Yoshiki Yasui.

Origami is betting that stores, which until now relied on direct mail and email newsletters, will pay for the ability to reach customers on their smartphones. For example, a hair salon using Origami’s payment app would be able to send a message to past customers with a coupon for their next haircut.

Quick Response codes, the dotted squares that can be read by smartphone cameras, were invented in the 1990s by a unit of Toyota Motor to track automotive parts. But when the Japanese pioneered digital payments almost two decades ago with contactless cards for train fares, they chose the so-called near-field communications technology. The high cost of rolling out NFC payments, convenient ATMs and a culture where lost wallets are often returned have all been cited as reasons why cash remains king in the archipelago. In China, however, QR codes dominate.

Cashless payments, which includes credit cards, accounted for just 20 per cent of total consumer spending in Japan during 2016, compared with 60 per cent in China and 89 per cent in South Korea, according to a report by the Bank of Japan.

The specs: 2018 Nissan 370Z Nismo

The specs: 2018 Nissan 370Z Nismo
Price, base / as tested: Dh182,178
Engine: 3.7-litre V6
Power: 350hp @ 7,400rpm
Torque: 374Nm @ 5,200rpm
Transmission: Seven-speed automatic
​​​​​​​Fuel consumption, combined: 10.5L / 100km

What the law says

Micro-retirement is not a recognised concept or employment status under Federal Decree Law No. 33 of 2021 on the Regulation of Labour Relations (as amended) (UAE Labour Law). As such, it reflects a voluntary work-life balance practice, rather than a recognised legal employment category, according to Dilini Loku, senior associate for law firm Gateley Middle East.

“Some companies may offer formal sabbatical policies or career break programmes; however, beyond such arrangements, there is no automatic right or statutory entitlement to extended breaks,” she explains.

“Any leave taken beyond statutory entitlements, such as annual leave, is typically regarded as unpaid leave in accordance with Article 33 of the UAE Labour Law. While employees may legally take unpaid leave, such requests are subject to the employer’s discretion and require approval.”

If an employee resigns to pursue micro-retirement, the employment contract is terminated, and the employer is under no legal obligation to rehire the employee in the future unless specific contractual agreements are in place (such as return-to-work arrangements), which are generally uncommon, Ms Loku adds.

Jetour T1 specs

Engine: 2-litre turbocharged

Power: 254hp

Torque: 390Nm

Price: From Dh126,000

Available: Now

The specs

AT4 Ultimate, as tested

Engine: 6.2-litre V8

Power: 420hp

Torque: 623Nm

Transmission: 10-speed automatic

Price: From Dh330,800 (Elevation: Dh236,400; AT4: Dh286,800; Denali: Dh345,800)

On sale: Now

WOMAN AND CHILD

Director: Saeed Roustaee

Starring: Parinaz Izadyar, Payman Maadi

Rating: 4/5

Updated: March 02, 2022, 11:07 PM`